Feature Channels:

Pharmaceuticals

Add to Favorites Subscribe Share
fbshare-Pharmaceuticals

Showing results

110 of 3587
mmc-logo.gif

Experimental cholesterol-lowering drug effective at lowering bad cholesterol, study shows

Mayo Clinic

Twice-yearly injections of an experimental cholesterol-lowering drug, inclisiran, were effective at reducing low-density lipoprotein (LDL) cholesterol, often called bad cholesterol, in patients already taking the maximum dose of statin drugs, according to data of the ORION-10 trial presented Saturday, Nov. 16, at the American Heart Association's Scientific Sessions 2019.

Channels: All Journal News, Cardiovascular Health, Heart Disease, Pharmaceuticals,

Released:
16-Nov-2019 11:55 AM EST
Embargo will expire:
19-Nov-2019 12:05 AM EST
Released to reporters:
15-Nov-2019 11:30 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 19-Nov-2019 12:05 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Research Results

Discovery reveals mechanism that turns herpes virus on and off

Cornell University

New research from Dr. Luis M. Schang and his group at the Baker Institute for Animal Health has identified a new mechanism that plays a role in controlling how the herpes virus alternates between dormant and active stages of infection.

Channels: All Journal News, Healthcare, Infectious Diseases, Pharmaceuticals, Vaccines,

Released:
14-Nov-2019 2:20 PM EST
Research Results
Newswise: Findings could help identify aggressive breast cancers that will respond to immunotherapy

Findings could help identify aggressive breast cancers that will respond to immunotherapy

University of North Carolina Health Care System

University of North Carolina Lineberger Comprehensive Cancer Center researchers have discovered a promising method to identify aggressive breast cancer tumors that will respond to drugs that unleash the immune system against cancer.

Channels: All Journal News, Cancer, Clinical Trials, Immunology, Pharmaceuticals, Women's Health,

Released:
14-Nov-2019 11:05 AM EST
Research Results
Newswise: Regular Use of Prescription Drugs for Pain 
and Sleep Increases Frailty Risk by 95 Percent

Regular Use of Prescription Drugs for Pain and Sleep Increases Frailty Risk by 95 Percent

Florida Atlantic University

Over eight years of follow-up, those who self-reported regular use of prescription drugs for pain and sleep had a 95 percent increased risk of frailty compared to those who did not report regular use of these drugs. For regular prescription drug use for pain only or for sleep only, the increased risks were 58 percent and 35 percent, respectively.

Channels: Aging, All Journal News, Pain, Pharmaceuticals, Seniors, Sleep,

Released:
14-Nov-2019 9:00 AM EST
Research Results
iu_logo.gif

FDA awards $1.7 million to IU and other universities for quality management research

Indiana University

The U.S. Food and Drug Administration has awarded $1.7 million to five universities, including Indiana University, for a wide-ranging research project designed to help the agency better understand how to employ its quality management resources when inspecting drug companies' manufacturing operations, thus benefiting consumers.

Channels: All Journal News, Drugs and Drug Abuse, Education, Pharmaceuticals, Grant Funded News,

Released:
14-Nov-2019 8:05 AM EST
Research Results

Law and Public Policy

Newswise: “Nudging” Heart Patients to Take Their Statins Leads to Better Medication Adherence and Better Patient Outcomes
  • Embargo expired:
    14-Nov-2019 5:00 AM EST

“Nudging” Heart Patients to Take Their Statins Leads to Better Medication Adherence and Better Patient Outcomes

Intermountain Healthcare

In a new study presented to heart specialists from around the world, researchers at the Intermountain Healthcare Heart Institute in Salt Lake City found that simple “nudges” in the form of texts, emails and phone calls, not only help patients fill that first statin prescription, but also continue to help them take their medications over the long term.

Channels: All Journal News, Cardiovascular Health, Healthcare, Heart Disease, Pharmaceuticals, Technology,

Released:
12-Nov-2019 1:25 PM EST
Announcement

Antibiotic Resistance Threats Report Shows Impacts of Federal Investments, Continued Gaps

Infectious Diseases Society of America (IDSA)

The Antibiotic Resistance Threats Report released by the U.S. Centers for Disease Prevention and Control today shows that while recent federal investments to combat antibiotic resistance have had meaningful impacts, the continued spread of infections that are not effectively treated by existing medicines pose deadly threats to patients and public health. As physicians and scientists on the front lines of a growing public health crisis, the Infectious Diseases Society of America urges federal policy makers to respond to the report’s warning with investments and commitment to turning the tide of antibiotic resistance.

Channels: All Journal News, Drug Resistance, Infectious Diseases, Pharmaceuticals, Public Health,

Released:
13-Nov-2019 2:10 PM EST
Research Results
Newswise: 216730_web.jpg

Opioid-based plant might not be best solution to curb habitual alcohol use

Purdue University

Lawmakers across the United States continue to debate the safety of kratom, an opioid-containing plant that has been listed as a "drug of concern" by the U.S. Food and Drug Administration. Kratom is sold over the counter in specialty stores and online.

Channels: Addiction, Alcohol and Alcoholism, All Journal News, Drugs and Drug Abuse, Economics, Entrepreneurship, Healthcare, Pharmaceuticals, Technology,

Released:
13-Nov-2019 2:05 PM EST
Research Results
image001.png
  • Embargo expired:
    13-Nov-2019 2:00 PM EST

Slowing the Progression of Multiple Sclerosis

Universite de Montreal

By identifying a molecule that delays the progression of MS, researchers pave the way for new therapies for the nearly 77,000 Canadians living with the disease.

Channels: All Journal News, Autoimmune Diseases, Neuro, Pharmaceuticals, Local - Canada, Grant Funded News,

Released:
12-Nov-2019 4:30 PM EST
Research Results

Showing results

110 of 3587

Chat now!
7.79203